Yüklüyor......
Immunotherapy and hyperprogression: Unwanted outcomes, unclear mechanism.
Hyperprogression (HP) is a recently defined clinical phenomenon in which patients treated with immunotherapy paradoxically exhibit rapid tumor growth. The mechanisms of HP remain ill-defined though recent studies in this issue point to a possible role for Fc receptors in this process.
Kaydedildi:
| Yayımlandı: | Clin Cancer Res |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6359946/ https://ncbi.nlm.nih.gov/pubmed/30397179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-18-3144 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|